Valbiotis SA (FR:ALVAL) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Valbiotis SA, a French scientific research company specializing in dietary supplements for metabolic disorders, has a share capital composed of 15,794,596 shares with voting rights listed on Euronext Growth Paris. The company is committed to revolutionizing health products by using marine and terrestrial plants, aiming for international licensing agreements while managing French marketing internally. Valbiotis benefits from significant EU financial support and holds the “Innovative Company” label, making it an attractive option for investors.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue